钆塞酸增强MRI与虚拟肝切除进行区域肝功能分析:预测HCC术后短期结局
该研究回顾性分析133例HCC患者,其中45例行开腹大范围肝切除,术前用钆塞酸增强MRI结合计算机辅助虚拟肝切除评估整体和区域肝功能,并与ICG试验对比,发现区域功能参数可预测术后肝衰竭和重大并发症,rT1ratio是重大并发症的独立危险因素。
要点
- 术前钆塞酸增强MRI结合虚拟肝切除可评估未来残肝体积和区域肝功能。
- 低rT1ratio(<66.5%)和高rT1pos(>217.5 ms)可能预测大范围肝切除后重大并发症。
- 肝功能储备良好(ICG<14%)且未来残肝体积充足(>30%标准肝体积)者未发生肝衰竭。
核心结论
- 术前钆塞酸增强MRI结合计算机辅助虚拟肝切除可能有助于优化评估区域肝功能储备,以预测HCC大范围肝切除后的短期结局。
研究设计与样本
- 回顾性分析133例连续HCC患者,均行术前钆塞酸增强MRI和ICG试验,其中45例接受开腹大范围肝切除。
- 采用计算机辅助虚拟肝切除评估肝功能储备和未来残肝;整体功能参数包括T1弛豫时间下降率(T1ratio)和功能性肝体积(FV),区域参数包括残肝的rT1pos、rT1ratio、残肝功能性体积(rFV)和残肝功能性体积比(rFVratio)。
- 以MRI和ICG功能参数预测大范围肝切除后短期结局(肝衰竭和重大并发症)。
诊断标准与关键数值
- T1ratio和FV与ICG试验相关(rho分别为-0.304和-0.449,p<0.05)。
- FV<682.8 ml提示术前ICG-R15≥14%,曲线下面积(AUC)为0.765。
- 低rT1ratio(<66.5%)和高rT1pos(>217.5 ms)可能预测重大并发症,AUC分别为0.831和0.756(p<0.05)。
- rT1ratio是术后重大并发症的独立危险因素(OR=0.845,95%CI 0.736-0.966;p<0.05)。
- 肝功能储备良好(ICG<14%)且未来残肝体积充足(>30%标准肝体积)者接受大范围切除后无患者发生肝衰竭。
临床应用与阅片要点
- 阅片时可结合虚拟肝切除测量残肝功能性体积和区域T1参数,辅助评估大范围肝切除风险。
- 报告区域肝功能时关注rT1ratio和rT1pos,低rT1ratio(<66.5%)和高rT1pos(>217.5 ms)可能与术后重大并发症相关。
- 作者认为术前钆塞酸增强MRI结合虚拟肝切除可能有助于优化区域肝功能储备评估。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: To explore the role of quantitative regional liver function assessed by preoperative gadoxetic acid-enhanced MRI with computer-aided virtual hepatectomy to predict short-term outcomes after major hepatectomy for HCC.
METHODS: We retrospectively reviewed the records of 133 consecutive patients with HCC who underwent preoperative gadoxetic acid-enhanced MRI and indocyanine green (ICG) test. Forty-five patients received open major hepatectomy. Liver function reserve and the future liver remnant were evaluated by computer-aided virtual hepatectomy. Global liver functional parameters included the T1 relaxation time reduction rate (T1ratio) and functional liver volume (FV), whereas regional parameters included the rT1pos, rT1ratio, remnant FV (rFV), and remnant FV ratio (rFVratio) of the remnant liver. The functional parameters of the MRI and ICG were used to predict the short-term outcomes (liver failure and major complications) after major hepatectomy.
RESULTS: The T1ratio and FV were correlated with the ICG test (rho = - 0.304 and - 0.449, p < 0.05). FV < 682.8 ml indicated preoperative ICG-R15 ≥ 14% with 0.765 value of the area under the curve (AUC). No patient who underwent major resection with good liver functional reserve (ICG < 14%) and enough future remnant volume (> 30% standard LV) developed liver failure. Low rT1ratio (< 66.5%) and high rT1pos (> 217.5 ms) may predict major complications (AUC = 0.831 and 0.756, respectively; p < 0.05). The rT1ratio was an independent risk factor for postoperative major complications (odds ratio [OR] = 0.845, 95% CI, 0.736-0.966; p < 0.05).
CONCLUSION: Preoperative gadoxetic acid-enhanced MRI with computer-aided virtual hepatectomy may facilitate optimal assessment of regional liver functional reserve to predict short-term outcomes after major hepatectomy for HCC.
KEY POINTS: • Preoperative gadoxetic acid-enhanced MRI with virtual hepatectomy and volumetric analysis can provide precise liver volume and regional functional assessment. • Quantitative regional liver function assessed by gadoxetic acid-enhanced MRI can predict the short-term outcomes after major hepatectomy in patients with HCC. • The regional liver function assessed by gadoxetic acid-enhanced MRI is an independent risk factor for postoperative major complications.
引用
- Huang M, Shen S, Cai H, et al. Regional liver function analysis with gadoxetic acid-enhanced MRI and virtual hepatectomy: prediction of postoperative short-term outcomes for HCC. Eur Radiol. 2021. PMID: 33449173. doi:10.1007/s00330-020-07606-x
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。